At the recent SCOPE Summit Europe in Barcelona – an excellent event with really good sessions and some great people in attendance – I was once again pleased to hear so many of the speakers talk about the good things that are happening in the industry.

I’ve mentioned before how it would be easy to come away from this type of conference thinking everything is right with clinical trials and the way they operate, then become disillusioned by observing what actually happens ‘on the ground’.

But actually I do think there is a sufficient groundswell of opinion for change – not just for its own sake, but change for the better.

Seeing examples of many of the initiatives that organizations within the industry are undertaking – including those from pharma, research sites, academic institutions, solutions providers etc. – left me with a sense that we are heading in the right direction.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...